Intelerad Medical Systems announced that the Intelerad Meaningful Use Module 2012 has achieved 2011/2012 Complete EHR (electronic health record) ONC-ATCB Certification, which designates that the software is capable of supporting providers with Stage 1 meaningful use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).

May 30, 2012  — ViewRay Inc., a privately held medical device company, has received U.S. Food and Drug Administration (FDA) 510(k) premarket notification clearance for its magnetic resonance guided (MRI)-guided radiation therapy system. The ViewRay system features a unique combination of radiotherapy delivery and simultaneous MRI for the treatment of cancer. ViewRay's treatment planning and delivery software received 510(k) premarket notification clearance in 2011.

May 30, 2012 — Bayer Radiology & Interventional will showcase new device technologies at the annual meeting of the Society of Nuclear Medicine (SNM) in Miami, June 9-13. The new technology includes enhancements to the Intego PET (positron emission tomography) Infusion System.

May 30, 2012 — Leroy Chiao, Ph.D., a former NASA astronaut, will share his experiences in performing and transmitting echocardiograms from outer space during a special presentation during the American Society of Echocardiography’s (ASE) 23rd Annual Scientific Sessions in National Harbor, Md., June 30-July 3. The session, “Hearts in Space”, planned for July 3 from 12:00-1:15 p.m., will give attendees insight into the medical aspects of the U.S. space program as well as the short- and long-term impact of weightlessness on cardiovascular function. The session will inform attendee’s clinical practice by relating remote diagnosis from space to terrestrial telemedicine.

May 29. 2012 — Viatronix Inc., developer of 2-D/3-D medical imaging and diagnostic software, announced that its V3D-Colon platform was exclusively used to perform a key study recently published in the Annals of Internal Medicine. The purpose of the study was to determine the feasibility of a laxative-free bowel prep for patients undergoing a virtual colonoscopy (VC) screening exam. The trial utilized a modified version of the Viatronix V3D-Colon software.

May 29, 2012 — Cianna Medical recently announced the launch of BEST (Brachytherapy Efficacy, Safety and Treatment) Forum, a new educational resource for physicians to obtain the latest research in breast brachytherapy and gain insights into best practices and available technology.

patient with lung cancer, MR/PET
The Philips Ingenuity TF PET/MR
the Biograph mMR MR/PET system

Magnetic resonance/positron emission tomography (MR/PET) is the newest imaging modality falling within the category of hybrid imaging. It sits at the crossroads of successful tradition and innovation. It is traditional in that it combines anatomical and functional molecular imaging from two potent imaging modalities; at the same time it is innovative, in that it combines the full potential of anatomic and multiparametric imaging of MRI with the molecular information of PET.

May 29, 2012 — Scientists have announced the discovery of intact red blood cells in some of the wounds found on Ötzi, the 5,300-year-old iceman whose body was discovered in 1991 in the Ötztal Alps and who is considered to be Europe’s oldest natural human mummy.

May 24, 2012 — Avaxia Biologics Inc., a privately held biotechnology company developing oral antibody drugs that act locally within the gastrointestinal tract, announced this week that the company was awarded U.S. Patent 8,182,818, entitled "Methods of Using Anti-TNF Antibodies for Treating Radiation Damage to the Digestive Tract."

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now